Editorial: HBeAg seroconversion is not sufficient to allow cessation of nucleos(t)ide analogue treatment in Caucasian hepatitis B patients.

Ingiliz, P

Editorial: HBeAg seroconversion is not sufficient to allow cessation of nucleos(t)ide analogue treatment in Caucasian hepatitis B patients. [electronic resource] - Alimentary pharmacology & therapeutics 06 2018 - 1551-1552 p. digital

Publication Type: Editorial; Comment

1365-2036

10.1111/apt.14649 doi


Fatal Outcome
Hepatitis B
Hepatitis B e Antigens
Hepatitis B, Chronic
Humans
Recurrence
Seroconversion